Afatinib in EGFR TKI-naïve patients with locally advanced or metastatic EGFR mutation-positive non-small cell lung cancer: Interim analysis of a Phase 3b study
Titel:
Afatinib in EGFR TKI-naïve patients with locally advanced or metastatic EGFR mutation-positive non-small cell lung cancer: Interim analysis of a Phase 3b study
Auteur:
de Marinis, Filippo Laktionov, Konstantin K. Poltoratskiy, Artem Egorova, Inna Hochmair, Maximilian Passaro, Antonio Migliorino, Maria Rita Metro, Giulio Gottfried, Maya Tsoi, Daphne Ostoros, Gyula Rizzato, Simona Mukhametshina, Guzel Z. Schumacher, Michael Novello, Silvia Dziadziuszko, Rafal Tang, Wenbo Clementi, Laura Cseh, Agnieszka Kowalski, Dariusz